BioCentury
ARTICLE | Company News

Wuxi gains commercialization rights to Tozaride in China from Andarix

September 15, 2017 6:10 PM UTC

Andarix Pharmaceuticals Inc. (Somerville, Mass.) granted Wuxi Fortune Pharmaceutical Co. Ltd. (Wuxi, China) commercialization rights in China for Tozaride to treat "lung and other cancers." Andarix said the companies will collaborate on clinical development of the compound...